Left ventricular hypertrophy (LVH) is an abnormal thickening of the left ventricular myocardium that occurs as an adaptive mechanism to increased afterload. The left ventricular myocytes ...

In the NOTIFY-LVH randomized clinical trial, a centralized population health coordinator–led notification and clinical support pathway for individuals with left ventricular hypertrophy on prior ...

Left ventricular hypertrophy can be diagnosed on ECG with good specificity. When the myocardium is hypertrophied, there is a larger mass of myocardium for electrical activation to pass through ...

A higher incidence of LVH associated with persistent nondipping pattern reasonably represents cardiac response to a sustained increase of LV systolic stress throughout the 24-h period. Thus ...

Aim Differentiating physiological cardiac hypertrophy from pathology is challenging when the athlete presents with extreme anthropometry. While upper normal limits exist for maximal left ventricular ...

Voltage criteria for LV hypertrophy (LVH) are frequently fulfilled, but correlate poorly with echocardiographic findings [16] and should not prompt further investigation in the absence of symptoms ...

left ventricular hypertrophy and increased mortality. This sequence of events can, therefore, justifiably be termed 'cardiorenal syndrome'. In contrast to cardiorenal syndrome, in which the ...

LV free wall = 7mm). The child is normoglycemic without medication. This patient's clinical course suggests a role for insulin in cardiac growth/hypertrophy. We recommend that infants with ...

HeartLung Technologies to debut its FDA designated "Breakthrough" AI technology (AutoChamberTM) at ACC 2025, offering lifesaving AI solutions for CVD prevention. Marlon Montes HeartLung Corporation +1 ...